D-Penicillamine-Induced Stevens–Johnson Syndrome in a Patient with Gold Cyanide Intoxication: A Case Report
Tanaporn Anuntrangsee,Kumutnart Chanprapaph,Wimolsiri Iamsumang
DOI: https://doi.org/10.2147/ccid.s489028
2024-10-28
Clinical Cosmetic and Investigational Dermatology
Abstract:Tanaporn Anuntrangsee, Kumutnart Chanprapaph, Wimolsiri Iamsumang Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand Correspondence: Wimolsiri Iamsumang, Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Rajthevi, Bangkok, 10400, Thailand, Tel +662-201-1141, Fax +662-201-1211, Email D-penicillamine is used as the mainstay of chelation therapy for Wilson's disease and for heavy metal intoxication. D-penicillamine itself has been noted to cause several systemic side effects as well as symptoms related to the skin. Common cutaneous side effects such as acute hypersensitivity reactions, elastic fiber abnormalities, and bullous diseases have been occasionally described. Herein, we report a case of a 23-year-old Thai female with gold intoxication who developed Stevens–Johnson syndrome (SJS) following the treatment of D-penicillamine. To our knowledge, D-penicillamine-induced SJS is exceptionally rare. To raise awareness of potentially fatal cutaneous adverse drug reaction triggered by D-penicillamine, published literature regarding SJS induced by this agent has also been reviewed. D-penicillamine should be regarded as a possible culprit in patients presenting with SJS following D-penicillamine administration and should be promptly discontinued. Keywords: chelating agent, cutaneous adverse drug reaction, cyanide, epidermal necrolysis, gold salt, penicillamine D-penicillamine or penicillamine (D-β, β-dimethylcysteine), a derivative of penicillin, is an amino acid with a thiol side chain, a carboxyl group, and an a-amine group. 1 It has been approved by Food and Drug Administration (FDA) as the mainstay for chelation therapy in patients with Wilson's disease, as well as cystinuria, and is considered as a conventional disease-modifying antirheumatic drug (DMARD). 2,3 As a chelating agent, it is used to treat heavy metal intoxication eg, copper, iron, mercury, arsenic, and lead. 4,5 With its toxic metabolites, D-penicillamine may cause a wide range of clinical adverse effects, presenting with either extra-cutaneous and cutaneous manifestations or both. Cutaneous reactions could range from autoimmune or degenerative dermatoses to hypersensitivity reactions. The common adverse events can be categorized according to their mechanisms into four groups including (1) acute hypersensitivity reactions, (2) dermopathies, (3) autoimmune disorders, and (4) miscellaneous dermatoses. 1 However, the occurrence of D-penicillamine-induced SJS is extremely rare as there are only a few publications in the literature regarding toxic epidermal necrolysis (TEN) or SJS/TEN induced by this medication. 6,7 We hereby present a case of SJS that occurred after taking D-penicillamine for the treatment of gold cyanide intoxication with confirmed enzyme-linked immunosorbent spot (ELISpot) test. A 23-year-old Thai female with an underlying disease of major depressive disorder presented to the emergency department with a complaint of acute onset of high-grade fever, painful oral ulcers, and generalized rash. Thirty-three days prior to the admission, she was diagnosed as having gold cyanide intoxication due to suicidal attempt. Then, she received intramuscular dimercaprol as the first anti-dote treatment for a total of 14 days. After clinical improvement, D-penicillamine was prescribed as the second treatment for detoxication with the initial dosage at 250 mg twice daily for one week followed by 500 mg twice daily for a couple of weeks. However, on day 12 after receiving D-penicillamine or 5 days prior to this visit, the patient developed fever and erythematous rash which started on the trunk and extended to the extremities. She also reported rash progression, sore mouth, and eye pain of 3 day-duration. She denied a history of previous herpetic infection. On examination, vital signs showed body temperature of 40 degree Celsius, blood pressure of 119/75 mmHg, pulse rate of 112 beats per minute, and respiratory rate of 24 breaths per minute. Dermatologic examination revealed generalized ill-defined non-blanchable erythematous to dusky red macules coalescing into patches with some central erosions on the face, trunk, and extremities including palms and soles (Figures 1A, 2 and 3A). Nikolsky's sign was positive on the truncal lesions (Figure 1B [inset]). The area of epidermal detachment was 8% of body surface area. She also had bilateral conjunctival injections (Figure 3A) and multiple oral erosions with some lesions on the lips having hemorrhagic crusts (Figure 3B). Other examinations were unremarkable. Further ophthalmic evaluation including slit-lamp examination was also within normal limits except for 1-millimeter corneal infiltration with -Abstract Truncated-
dermatology